A West Coast biotech entrepreneur says he’s secured $30 million to form a public-benefit company to study how to safely create genetically edited babies, marking the largest known investment into the ...
Chocolate prices have been rising due to complications in the supply chain, but Penn State researchers have made a ...
As we look ahead in 2025, the pace of discovery in genetics continues to accelerate, marking the third decade of the 21st century with remarkable ...
They're exploring its use for groundbreaking treatments for cancer and autoimmune disease, as well as for gene-editing ...
Cathy Tie, who launched her first biotech in SF's IndieBio, now leads Manhattan Genomics in controversial push to edit human ...
Intellia Therapeutics, Inc. is rated Hold due to uncertainty from dosing pause in its MAGNITUDE program for ATTR. Learn more ...
Seven years after the first gene-edited babies were revealed, biotech startup Manhattan Genomics is reviving the idea of ...
Scientists are on the brink of even preventing some diseases — not just treating them — at the sperm, egg and early embryo ...
New scientific article warns of loss of consumer trust unless proper analysis is done. Report: Claire Robinson ...
Organoids, three-dimensional cultures derived from stem cells, have rapidly emerged as a transformative technology within biomedical research. By closely ...
Joe Scott on MSN
How Scientists Actually Use Gene Editing to Fight Cancer
How can altering DNA help defeat one of the world’s deadliest diseases? This video explores how scientists are using CRISPR ...
Traditional breeding and genetic modification methods have struggled to keep pace with the rapid evolution of plant viruses. CRISPR/Cas systems, originally derived from bacterial immune responses, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback